Molecular targeting therapies for neuroblastoma: Progress and challenges

There is an urgent need to identify novel therapies for childhood cancers. Neuroblastoma is the most common pediatric solid tumor, and accounts for ~15% of childhood cancer‐related mortality. Neuroblastomas exhibit genetic, morphological and clinical heterogeneity, which limits the efficacy of exist...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafar, Atif, Wang, Wei, Liu, Gang, Wang, Xinjie, Xian, Wa, McKeon, Frank, Foster, Jennifer, Zhou, Jia, Zhang, Ruiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906923/
https://www.ncbi.nlm.nih.gov/pubmed/33155698
http://dx.doi.org/10.1002/med.21750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906923/
https://www.ncbi.nlm.nih.gov/pubmed/33155698
http://dx.doi.org/10.1002/med.21750

Ejemplares similares